KIR haplotypes and their Centromeric (Cen) and Telomeric (Tel) motifs have been shown to affect HCT outcome for unrelated donor donor transplantation in AML patients. Little is known regarding KIR haplotype matching. HLA and KIR segregate independently. Only 25% of sibling donors were expected to be KIR fully matched with the patient. Our pilot study included 108 AML patients transplanted in complete remission at City of Hope (2005) (2006) (2007) (2008) (2009) . The patient and HLA-fully matched sibling donor were typed for KIR genes and 3DL1 alleles (SSP-Multiplex). We sequenced 3DL1/ 3DS1 alleles and Ig domains for 3DL2 and 3DL3 genes. A KIR-fully matched pair is defined patient and donor share the same KIR genotype, have identical 3DL1/S1 alleles, and the same SNP for 3DL2 and 3DL3. 24 (22%) patients had KIR fully matched donors. Interestingly, if the patient and sibling had identical Bx KIR genotypes, then their 3DL1 alleles or 3DL2/3 SNP were also identical, with only few exceptions (8/28), which is not true for AA patient/donor combination (14/18 AA pairs) . The data appears to confirm that KIR B haplotypes are less diverse in terms of KIR alleles than KIR A haplotypes. Therefore, if the patient and sibling are identical based on KIR Bx genotypes, most probably they are KIR fully matched (70% probability).
Patients with fully matched KIR donors have similar relapse and aGVHD rates however, disease free survival is slightly higher (RR 5 0.553; 95%CI 5 0.23-1.3; P 5 NS). Patients with KIR Bx donor genotype have a higher incidence of aGVHD (RR 5 1.96; 95% CI 5 1.03-2.73; p 5 0.04), due to Tel-Bx motif (RR 5 2.06; 95% CI 5 1.2-3.5; p 5 0.009). Higher donor B content is associated with increased aGVHD (RR 5 1.94; 95%CI 5 1.12-3.34; p 5 0.018). Non of those parameters had any impact on rates of relapse, or disease-free survival.
In conclusion, KIR haplotype matching does not appear to affect related HCT outcome. However, KIR B haploype was associated with aGVHD. These results suggest that inclusion of ALL patients may reveal greater impact of the KIR genes on HCT.
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THE IMPACT OF SINGLE CLASS I HLA-ANTIGEN MISMATCH ON OUTCOME OF CHILDREN UNDERGOING HEMATOPOIETIC CELL TRANSPLANTATION FROM RELATED DONORS Ayas, M., Al-Seraihy, A., Siddiqui, K., Al-Jefri, A., Al-Ahmari, A., Khairi, A., Shaheen, H., Markiz, S., El-Solh, H. King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
Several studies have shown that single class I HLA-antigen mismatches adversely affect the outcome of hematopoietic cell transplantation (HCT) from unrelated donors. Few data are however available on the significance of such mismatch in related donor HCT, particularly in children. This study was designed to retrospectively compare the outcomes of children who underwent HCT from HLA class I single antigen mismatched related donors and children who underwent HCT from fully matched related donors. Patients and Methods: 38 patients (pts), age #14 years, underwent HCT from HLA class I single antigen mismatched related donors from January 1993 to December 2010 at King Faisal Specialist Hospital & Research Center. Out of this group, 30 pts (the study group: MIS) were matched with 90 pts that underwent HCT from fully matched related donors (the control group: MRD) with respect to age, gender, donor gender, indication for HCT, donor relationship and source of stem cells. Results: There were 18 males in MIS and 55 in MRD (P 5 1.00). Median age at HCT was 2.1 years in MIS and 4.5 years in MRD (P 5 0.4). The locus of mismatch was A in 22 pts and B in 8 pts. Median follow up time was 5.7 years (95% CI: 2.5-8.8) in MIS and 4.6 years (95% CI: 2.9-6.4) in MRD. Incidence of Acute graft vs. host disease (aGVHD) was 63% (19 pts) in MIS and 35% (32 pts) in MRD (P 5 0.01), and the incidence of severe (grade III-IV) aGVHD was 33.3% (10 pts) and 9% (8 pts) in the 2 groups (P 5 0.007). One hundred pts were evaluable for chronic graft vs.host disease (cGVHD), 23 in MIS and 77 in MRD. Incidence of cGVHD was 26.1% (6 pts) in MIS and 6.5% (5 pts) in MRD (P 5 0.017). Among MIS, 13 % (3 pts) experienced extensive cGVHD in contrast to 3.9% (3 pts) in MRD (P 5 0.029). Incidence of Graft Failure (Primary/secondary) was not different in the 2 groups; 40% (12 pts) in MIS compared to 27.8% (25 pts) in MRD (P 5 0.26). No significant difference was found between the overall survival (OS) of the pts from MIS (55%) and MRD (38%) (P 5 0.072). However, pts in MRD had a significantly better Event Free Survival (EFS) of 32% compared to 21% in MIS (P 5 0.027); events were defined as primary/secondary graft failure, relapse of primary disease, or death. Conclusion: Our analysis demonstrates that in related donor HCT, a single antigen, HLA-class I mismatch is associated with a significantly higher risk of acute and chronic GVHD, and with a lower survival when compared with HCT from fully matched related donors. We are investigating genetic ancestry in transplant pairs as a means to understand differences in outcomes across ethnic groups and also as a potentially informative new parameter of matching.
Genetic ancestry of transplanted patient/donor pairs was analyzed using two types of ancestry informative markers (AIMs): HLA and SNPs. The dataset included 491 individuals (76 African-American (AFA), 48 Asian/Pacific Islanders (API), 243 Caucasian (CAU), 104 Hispanic (HIS) and 20 Native American (NAM)) genotyped for HLA-A, -B, -C, -DRB1 and -DQB1 and 30 autosomal SNPs from a published (Nassir 2009) reference AIMs panel. 23 of the chosen SNPs had .40% allele frequency difference between AFA and CAU, 23 .40% difference between AFA and API, and 9 .40% difference between CAU and API. Out of the last 9 SNPs, only one had a difference .40% between CAU and South Asian (SAS) and three between East Asian (EAS) and SAS. Assignment of admixture proportions was determined using STRUCTURE v2.3.2. Preliminary results recaptured ancestry of self-identified AFA, EAS and CAU individuals, however distinguishing SAS from CAU individuals proved challenging due to sample size disparities and the lack of sufficiently differentiating SNPs. When the pilot cohort was augmented with EAS and SAS individuals from the published reference cohort (Nassir 2009) to balance sample proportions, SAS individuals emerged as a separate cluster distinct from EAS and CAU.
We additionally used Bayesian inference to assign racial categories to the pilot cohort using HLA AIMs. The algorithm used reference haplotype frequencies and knowledge of population sizes within the Be The MatchÒ Registry as priors to calculate the overall likelihood of a race assignment. Classifying race using HLA frequencies gave .80% recovery of self-identified race for AFA and API, with lower recovery for CAU, HIS, and NAM. HLA ancestry classification is used as a supplement to ancestry classification using SNP AIMs.
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